Drugs / Ure-Na
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04727606 | Jan 2023 → Jan 2024 | nephrolithiasis | University of Montreal Hospital Centre (CHUM) | Withdrawn | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ure-Na | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04727606 ↗ |
| Known as | Oral Urea | “Participants in the study will receive Oral Urea (Ure-Na) treatment at a dose of 30 grams per day (2 x 15 gram pouches per day)” NCT04727606 ↗ |
| Modality | Other / unclassified | “Ure-Na (osmotic agent) taking could help to increase urine volume and decrease urine concentration” NCT04727606 ↗ |
| Route | Oral | “Participants in the study will receive Oral Urea (Ure-Na) treatment” NCT04727606 ↗ |